1. Levofloxacin is an intravenous antibiotic used to treat various bacterial infections.
2. AuroMedics initiated the recall after receiving a customer complaint of white particulate matter in the injection solution. The company tentatively identified the substance as mold.
3. Use of a nonsterile injection could cause serious or fatal infections in patients. However, AuroMedics has not received any reports of adverse events related to the recalled product.
4. The company is notifying its hospital customers of the recall and arranging for the return of all affected products.
More articles on supply chain:
Mylan reaffirms $1B share buyback plan
Dr. Reddy’s recalls 1k cancer drug vials over container defect: 4 things to know
6 must-reads for supply chain leaders
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
